SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020194
Filing Date
2018-08-08
Accepted
2018-08-08 07:52:08
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20180630.htm 10-Q 3058447
2 EX-31.1 rgnx-ex311_6.htm EX-31.1 17084
3 EX-31.2 rgnx-ex312_7.htm EX-31.2 16912
4 EX-32.1 rgnx-ex321_8.htm EX-32.1 11300
  Complete submission text file 0001564590-18-020194.txt   12640570

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgnx-20180630.xml EX-101.INS 3666611
6 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20180630.xsd EX-101.SCH 54043
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20180630_cal.xml EX-101.CAL 55975
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20180630_def.xml EX-101.DEF 237983
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20180630_lab.xml EX-101.LAB 421696
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20180630_pre.xml EX-101.PRE 367186
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 18999840
SIC: 2836 Biological Products, (No Diagnostic Substances)